| Popis: |
Nanotechnology is one of the most developing sciences in the current century. The utilization of this new technology in the diagnosis and treatment of some ailment, including cancer, is pivotal in the biomedical field. However, very limited approvals have been approached to use nanomaterials in the medical field. The toxicity and safety issues are essential concerns when scientists gain the outcomes of the nanoparticle application. A broad range of investigations has been undertaken to assess in vivo and in vitro toxicity for various nanomaterials. In this chapter, we summarized the most recent outcomes of the nanomaterials toxicity investigates. Generally, more effort needs to be conducted to reach a wise decision about the use of the safest formulation of nanoparticles in the treatment of human cancer. Nevertheless, ligand-specific nanoparticles seem to be the best option for the development of nanomaterials as a treatment preference for human cancers. Despite the outcomes of different in vitro and in vivo experiments, there is an essential need for unifying the experimental approaches to reach the right conclusions to establish nanomaterial toxicity. |
